Skip to main content
. Author manuscript; available in PMC: 2013 Dec 23.
Published in final edited form as: Int J Gynecol Cancer. 2011 Apr;21(3):10.1097/IGC.0b013e31820cc305. doi: 10.1097/IGC.0b013e31820cc305

Table 2.

Clinical Characteristics of the 2009 Stage I (N=1411) endometrioid adenocarcinoma patients.

Variable Count Percent (%)
Vital Status
  AWD 44 3.1
  NED 1267 89.8
  DOD 56 4
  DOO 44 3.1

Age at Diagnosis
  Median(Mean) 60(60.66)
  Range 25~92

2009 Stage
  IA 1249 88.5
  IB 162 11.5

Final Grade (missing=3)
  1 630 44.7
  2 550 39.1
  3 228 16.2

Depth of Invasion
  <50% 663 47
  >50% 162 11.5
  none 586 41.5

Nodes Taken
  None 540 38.3
  Yes 871 61.7

 Total Lymph Nodes Taken>=1
  Median(Mean) 19(19.76)
  Range 1~92
 Total Pelvic Nodes Taken>=1
  Median(Mean) 15(16.07)
  Range 1~80
 Total Aortic Nodes Taken>=1
  Median(Mean) 5(6.14)
  Range 1~26

Height at Diagnosis (missing=121)
  Median(Mean) 160(159.72)
  Range 57.5~186

Weight at Diagnosis (missing=74)
  Median(Mean) 76(81.48)
  Range 37~208.6

LVI (missing=880)
  NO 440 82.9
  YES 87 16.4
  NA 4 0.8